Discovery of the First-in-class G9a/GLP PROTAC Degrader

Julia Velez(Icahn School of Medicine at Mount Sinai), Jian Jin(Icahn School of Medicine at Mount Sinai)
bioRxiv (Cold Spring Harbor Laboratory)
February 29, 2024
10.1101/2024.02.26.582210
Cited by 2

Related Papers

A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases
|ACS Chemical Biology|2015|290
Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53
|Journal of the American Chemical Society|2023|53
Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer
|Journal of Medicinal Chemistry|2023|50
Discovery of a novel, highly potent EZH2 PROTAC degrader for targeting non-canonical oncogenic functions of EZH2
|European Journal of Medicinal Chemistry|2024|36
Targeted Degradation of PRC1 Components, BMI1 and RING1B, via a Novel Protein Complex Degrader Strategy
|Advanced Science|2023|25